Top Markets
#1 Trillions Trillions +5,128.37%
#2 DeFiChain DeFiChain +1,700.88%
#3 Bedrock Bedrock +163.86%
#4 Siren Siren +91.29%
#5 KONET KONET +60.65%
#6 inSure DeFi inSure DeFi +59.52%
#7 Banana For Scale Banana For Scale +44.28%
#8 Aria.AI Aria.AI +38.69%
#9 Syndicate Syndicate +37.36%
#10 Janction Janction +32.88%
Coin of the day
Trillions Trillions
설정
언어
한국어
통화
USD
테마
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
주식 순위 #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
주가
$0.09933121
시가총액
$29.15K
변동 (1일)
0.57%
변동 (1년)
449.49%
국가
IE
거래 Ovoca Bio plc (OVB)

카테고리

Healthcare
Ovoca Bio plc (OVB)의 매출
Jun 2024 기준 매출 TTM: 0.00
Ovoca Bio plc의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0.00입니다. 2023년에 회사는 0.00의 수익을 올렸으며 이는 2022년의 0.00 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Ovoca Bio plc의 수익 기록 (2001 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
2010 0.00 0.00%
2009 0.00 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
2001 0.00 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $48.44B -
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.04B -
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $14.34B -
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.08B -
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $5.49B -
NL